Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo
Article in Biomedicine & Pharmacotherapy (March 2024)
The most recent citing publications are shown below. View all 65 publications that cite this research output on Dimensions.
mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions
Article in Cell Death & Disease (November 2023)
Everolimus combined with PD-1 blockade inhibits progression of triple-negative breast cancer
Article in Cellular Signalling (May 2023)